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ell death is an intrinsic part of metazoan de-
velopment and mammalian immune regulation.
Whereas the molecular events orchestrating
apoptosis have been characterized extensively, little is
known about the biochemistry of necrotic cell death.
Here, we show that, in contrast to apoptosis, the induc-
tion of necrosis does not lead to the shut down of protein
synthesis. The rapid drop in protein synthesis observed in
apoptosis correlates with caspase-dependent breakdown of
eukaryotic translation initiation factor (eIF) 4G, activation of
C
 
the double-stranded RNA-activated protein kinase PKR,
and phosphorylation of its substrate eIF2-
 
 
 
. In necro-
sis induced by tumor necrosis factor, double-stranded
RNA, or viral infection, de novo protein synthesis per-
sists and 28S ribosomal RNA fragmentation, eIF2-
 
 
 
phosphorylation, and proteolytic activation of PKR are
absent. Collectively, these results show that, in contrast to
apoptotic cells, necrotic dying cells retain the opportunity
to synthesize proteins.
 
Introduction
 
Cell death is an essential part of metazoan development, ho-
meostasis, and mammalian immune regulation. Based on the
typical morphological features that become apparent in the
course of cellular demise, three major types of cell death have
been discerned: apoptosis, autophagic cell death, and necrosis
(Schweichel and Merker, 1973; Clarke, 1990). The characteristic
features of apoptosis, such as blebbing of the cell membrane,
condensation of the nucleus, and internucleosomal cleavage of
DNA, are a direct or indirect consequence of the activation of
caspases (Hengartner, 2000; Lamkanfi et al., 2002). Autopha-
gic cell death is characterized by extensive autophagy and
appears in development as well as in pathological conditions
such as Parkinson’s disease and muscle diseases (Levine and
Klionsky, 2004). The most prominent feature of necrosis is
swelling (oncosis) of the cell and its organelles followed by
loss of cell membrane integrity. Necrosis has often been con-
sidered as a passive process, lacking underlying signaling
events. This assumption might hold for cell death resulting
from severe physical or environmental damage such as hyper-
thermia or dounce- and detergent-induced lysis. However,
necrotic cell death also occurs in normal physiological settings
such as intestinal epithelium homeostasis (Barkla and Gibson,
1999). Necrosis is observed in various pathophysiological con-
ditions such as cardiac ischemia and diseases associated with
neuronal cell death such as stroke, amyotrophic lateral sclerosis,
and Alzheimer’s, Huntington’s, and Parkinson’s diseases (Col-
bourne et al., 1999; Nicotera et al., 1999). Furthermore, when
caspase activation is prevented, necrosis can substitute for
canonical caspase-dependent apoptosis induced by, for example,
TNF, TNF-related apoptosis-inducing ligand, Fas ligand, and
double-stranded RNA (dsRNA; Vercammen et al., 1998; Kalai
et al., 2002; Vanden Berghe et al., 2003) and during digit for-
mation in the developing mouse embryo (Chautan et al., 1999).
Convincing evidence for the existence of a programmed
necrotic pathway was reported by Holler et al. (2000), who
demonstrated that death domain receptor–induced necrosis of
human T lymphocytes requires functional receptor interacting
serine/threonine protein kinase 1 (RIP1). Dimerization of Fas-
associated death domain (FADD) induces necrosis in caspase-8–
deficient Jurkat T cells (Kawahara et al., 1998) and in the
mouse L929 fibrosarcoma cell line in a RIP1-dependent way
(Vanden Berghe et al., 2004). In line with this finding, RIP1- and
FADD-deficient mouse embryonic fibroblasts prove resistant to
necrosis induced by TNF in the presence of the pan-caspase
inhibitor benzyloxycarbonyl-Val-Ala-DL-Asp(OMe)-fluoro-
methylketone (zVAD-fmk; Lin et al., 2004). Nevertheless, insight
in the molecular events that operate during necrosis is still limited.
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Induction of apoptosis is characterized by a general inhi-
bition of protein synthesis that is attributed to the proteolytic
attack of translation initiation factors (Clemens et al., 2000).
Because the effect of necrotic cell death on the translational
machinery has not been examined, we compared the protein
synthesis capacity of cells subjected to apoptotic or necrotic
death stimuli. We show that after necrosis, protein synthesis is
sustained in the dying cell, up to the point where the cell loses
its membrane integrity.
 
Results and discussion
 
dsRNA and TNF induce necrosis in 
Jurkat T cell clones
 
To test if protein synthesis is disturbed during a necrotic re-
sponse, we made use of three different Jurkat T cell lines. Wild-
type cells (Jurkat E [JE]) respond to Fas-ligation by apoptosis
and were used as control. As a first model of necrosis we chose
dsRNA treatment of JB6 cells. These cells, genetically deficient
in caspase-8 and overexpressing Bcl-2, die in a necrotic way in
response to dsRNA, unlike JE cells, which hardly respond to
dsRNA (Kalai et al., 2002). In a second model, we used death
receptor–induced necrosis of FADD-deficient cells stimulated
with TNF (TNF was used because, in our hands, Fas-ligation in
the absence of caspase-8 or FADD or in the presence of caspase
inhibitors barely induced necrosis). As expected, JE cells treated
with agonistic anti-Fas antibody displayed blebbing of the cell
membrane and little or no propidium iodide (PI) staining at the
early stage of apoptosis (Fig. 1 A). Treatment of JB6 cells with
dsRNA or of FADD-deficient cells with TNF induced swelling
of the cells, followed by cellular collapse and loss of membrane
integrity. To further differentiate between cell death types, the
generation of reactive oxygen species (ROS) was assessed. An
increase in ROS production was detected starting 2–4 h after
stimulation in necrotic but not in apoptotic cells (Fig. 1 B). Fi-
nally, the caspase inhibitors zVAD-fmk and qVD-OPH failed to
prevent necrotic cell death (Fig. 1 C).
 
The rate of protein synthesis remains 
constant during necrosis
 
To compare de novo protein synthesis in the course of apopto-
sis and necrosis, cells were pulse-labeled with 
 
35
 
S-methionine
at various time points after induction of cell death. In agree-
ment with previous reports, induction of apoptosis in JE cells
resulted in a rapid decrease in de novo protein synthesis that
was already apparent 2 h after treatment with agonistic anti-Fas
antibody (Fig. 2 A and Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200407162/DC1). In contrast, the rate of
protein synthesis in JB6 cells treated with dsRNA and in
FADD-deficient cells exposed to TNF was not affected up to
8 h after treatment, when the majority of the cells had already
lost membrane integrity. The kinetics of cell death, determined
by the loss of membrane integrity, were similar in the apoptotic
and necrotic settings (Fig. 2 A). We conclude that necrosis in-
duced by dsRNA or TNF in Jurkat cells does not affect the
overall protein synthesis capacity of the cells destined to die.
Pulse-labeling experiments of mouse L929 cells stimulated to
Figure 1. dsRNA and TNF induce necrosis in JB6 and FADD-deficient Jurkat
cells. (A) Microscopic analysis. JE cells were treated with anti-Fas antibody to
induce apoptosis (top), JB6 cells with dsRNA (middle), and FADD-deficient
cells with TNF (bottom). Photomicrographs were taken after 4 (JE) and 6 h
(JB6 and FADD-deficient cells). Apoptotic cells showing blebbing of the cell
membrane and necrotic cells displaying swelling are indicated (closed ar-
rows). In the middle and right columns, cells with nuclear PI staining are indi-
cated with open arrowheads. (B) Cells were treated with anti-Fas (JE), dsRNA
(JB6), or TNF (FADD
 ) or left untreated (CTR) for the indicated time periods.
ROS production was determined by measuring the fluorescence intensity of
rhodamine 123 in PI-negative cells. Bars represent mean values from three ex-
periments, relative to time 0 (set to 100%). (C) Cells, pretreated for 30 min
with 25  M zVAD-fmk, quinoline-Val-Asp-O-phenoxy (q-VD-OPH), or DMSO,
were stimulated with anti-Fas (JE), dsRNA (JB6), or TNF (FADD
 ) for 8 h. Con-
trol (CTR) cells were not stimulated. Error bars equal SD of the mean (n   3). 
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die necrotically or apoptotically confirmed that the rate of pro-
tein synthesis is not overtly affected in necrosis, whereas trans-
lation is rapidly shut down in apoptosis (Fig. 2 B).
 
The protein synthesis machinery remains 
intact during necrosis
 
The initiation phase of protein synthesis constitutes the major
site of its regulation. Eukaryotic translation initiation factor
(eIF) 4G is a prime determinant in eukaryotic translation initia-
tion because it provides the molecular bridge between the
mRNA and the ribosome (Pestova et al., 2001). Caspase-depen-
dent as well as caspase-independent cleavage of eIF4G has been
reported and this event correlates with the shut down of protein
synthesis (Clemens et al., 2000). Because protease activity may
contribute to necrosis, we assessed the integrity of eIF4G by im-
munoblotting. In cells treated with anti-Fas, a 45-kD fragment
of eIF4G was clearly detected (Fig. 3 A). In contrast, no genera-
tion of eIF4G fragments in dsRNA- or TNF-induced necrosis
was found. Next, we examined the modification of translation
initiation factor eIF2-
 
 
 
 in apoptotic and necrotic cells. eIF2-
 
 
 
 is
a subunit of the heterotrimeric eukaryotic translation initiation
factor eIF2, which mediates the binding of initiator Met-tRNAi
to the 40S ribosomal subunit. eIF2-
 
 
 
 phosphorylation leads to
translation inhibition and in apoptosis coincides with caspase-
dependent cleavage and activation of the eIF2-
 
 
 
 kinase dsRNA-
activated protein kinase (PKR; Saelens et al., 2001). eIF2-
 
 
 
phosphorylation increased 2 h after anti-Fas treatment, coincid-
ing with eIF4G cleavage, PKR cleavage, and the drop in the rate
of translation (Figs. 2 A and 3 A). No PKR cleavage or signifi-
cant eIF2-
 
 
 
 phosphorylation was observed in either necrotic
system. DsRNA is a potent activator of PKR, and extracellu-
larly administered poly-inosinic-cytidylic acid can activate PKR
in a TRIF (TIR domain-containing adaptor inducing IFN-
 
 
 
)-
dependent manner (Hsu et al., 2004). The lack of PKR activa-
tion in JB6 cells exposed to dsRNA is somewhat surprising. It is
possible that the TLR3 pathway in JB6 cells, which have a
strong antiapoptotic constellation (overexpression of Bcl-2 and
lack of caspase-8), favors RIP1-mediated necrosis (Kalai et al.,
2002), a condition that may interfere with PKR activation.
Cleavage of 28S ribosomal RNA (rRNA) in a caspase-
dependent or -independent way has been shown to correlate
with inhibition of protein synthesis in cell death, and therefore
was also analyzed (Houge et al., 1995). Apoptotic cells dis-
played two distinct RNA bands reportedly derived from 28S
rRNA (Fig. 3 B; Houge et al., 1995). In contrast, the induction
of necrosis by dsRNA treatment of JB6 cells and by TNF treat-
ment of FADD-deficient cells did not generate detectable
rRNA alterations, which is in line with the ability of the cell to
maintain protein synthesis (Fig. 3 B).
 
Necrosis in wild-type Jurkat cells
 
To ascertain the physiological relevance of necrosis in wild-type
JE, we monitored cell death induced by a nonenveloped, cy-
tolytic virus. We found that coxsackievirus B (CVB), an en-
Figure 2. Translation is rapidly shut down in apoptosis
but not in necrosis. (A) Protein synthesis in Jurkat cells was
analyzed by pulse-labeling cells for 30 min with 10  Ci
35S-methionine in normal medium at various time points after
stimulation. Pulse-labeling was also performed on unstimu-
lated cells treated for 1 h with 10  g/ml CHX and on cells
stimulated for 6 h with anti-Fas, dsRNA, or TNF together with
CHX added 1 h before addition of 
35S-methionine. After label-
ing, cells were lysed and 30- g samples were resolved by SDS-
PAGE followed by Coomassie staining and autoradiography.
Coomassie and radioactivity signals from gels were quanti-
fied by densitometry and phosphorimaging, respectively, and
the ratio of 
35S-counts over total protein in each lane was cal-
culated (top). Cell death from cells used for pulse-labeling
experiments was determined by trypan blue exclusion (bot-
tom). (B) The rate of protein synthesis remains constant during
TNF-induced necrosis in mouse L929 fibrosarcoma cells.
L929sAFas cells were seeded at 2.5   10
5 cells/ml in sus-
pension plates on the day before labeling with 
35S-methionine.
30-min pulse-labeling was performed at different time points
after stimulation with 100 ng/ml anti-Fas (left) or 5,000 IU/ml
TNF (right) to induce apoptosis and necrosis, respectively
(top). CHX (10  g/ml; 1 h)-treated cells were also included.
Cell lysates were prepared and analyzed by measuring scin-
tillation counts of TCA-precipitated cell extracts (anti-Fas–
treated cells) or by SDS-PAGE followed by Coomassie stain-
ing and autoradiography (TNF-treated cells). 
35S scintillation
counts of anti-Fas–treated cells are depicted (left). For TNF-
treated cells, 
35S counts in each lane of the gels were quanti-
tated using a phosphorimager and represented as mean values
from three independent experiments (right). Cell death in the
same experiment was monitored by trypan blue exclusion
(bottom). Data in A and B represent mean values and error
bars indicate the SD of the mean (n   3). 
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terovirus belonging to the 
 
Picornaviridae
 
 family, induces necro-
sis-like cell death in both JE and JB6 cells. CVB replicated
efficiently in both cell lines and induced swelling of the cells
followed by loss of membrane integrity (Fig. 4, A and B). Vi-
rus-induced cell death, which became apparent 6 h after infec-
tion, proceeded without caspase activity or poly(ADP-ribose)
polymerase (PARP) cleavage (Fig. 4, C, D, and F). CVB infec-
tion had little, if any, effect on protein synthesis in both cell
lines (Fig. 4 E). eIF4G analysis showed the generation of a 100-
kD COOH-terminal fragment (Fig. 4 F), an event that is typi-
cally observed in enterovirus-infected cells (Etchison et al.,
1982) and that has been implicated in the virus-induced switch
from cap-dependent host cell translation to IRES-driven transla-
tion of the viral genome (Ehrenfeld, 1982). The morphology of
the dying cells and the absence of caspase activation strongly in-
dicate that even apoptosis-competent cells can die by necrosis,
e.g., following a viral infection. Finally, we also analyzed the ef-
fect of an apoptotic and a necrotic stimulus on CVB replication.
We found that anti-Fas treatment of infected JE cells suppresses
translation and viral progeny by 10-fold (Fig. 5, A and C). In
contrast, enhancing necrosis by dsRNA treatment of infected
JB6 cells did not affect translation or CVB propagation (Fig. 5,
B and D). This finding provides evidence that CVB can effi-
ciently propagate in translationally active cells dying of necrosis
but not in apoptotic cells in which protein synthesis is blocked.
 
Physiological implications of ongoing 
translation in necrosis
 
Our results demonstrate that necrosis induced by dsRNA or TNF
treatment of Jurkat T lymphocytes and by TNF in L929 fibrosar-
coma cells does not affect the protein synthesis rate. DsRNA and
TNF give rise to a rapid and strong induction of gene expression
as evidenced by the phosphorylation status of p38 MAPK (unpub-
lished data). In a cell destined to die by necrosis, translation of
newly synthesized transcripts could still occur, resulting for
example in gene products that may alert other cells in a local or
Figure 3. Translation initiation factors eIF4G,
eIF2- , PKR, and PARP remain intact in necrosis
but not in apoptosis. (A) Western blot analysis
of total cell lysates reveals the cleavage of
eIF4G into a 45-kD fragment (eIF4G C-FAG)
in time after anti-Fas treatment of JE cells (left).
Asterisks denote an aspecific band. The phos-
phorylation status of eIF2-  was monitored
using an antibody specific for eIF2-  phos-
phorylated at Ser51 (P-eIF2- ). The total
amount of eIF2-  was also assessed on the
same blot after inactivation of the P-eIF2-  sig-
nal by overnight treatment of the blot with
0.1% NaN3. The ratio of phosphorylated over
total eIF2-  signal per lane was determined by
densitometric analysis, normalized to 1 for
time 0, and is indicated below each lane. Im-
munoblots for PKR and PARP show the appear-
ance of a 40-kD PKR fragment (PKR-Nterm)
and of an 85-kD fragment of PARP in apopto-
sis. (B) Ribosomal 28S RNA is cleaved in
apoptosis but not in necrosis. 10  g of total
RNA isolated from cells treated as indicated
was analyzed by agarose gel electrophore-
sis followed by ethidium bromide staining.
Arrows indicate the position of 28S and
18S  rRNA. Arrowheads indicate cleavage
products in the anti-Fas–treated sample. CTR,
untreated. 
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systemic fashion. Apoptosis is often considered as a “clean death”
because it prevents the release of the intracellular content of the
cell. Rapid inhibition of translation may contribute to keep apop-
totic cell demise immunologically silent. Moreover, apoptosis can
be considered as an antiviral host cell response aimed at curtailing
virus replication. In contrast, necrotic cell death and spilling of the
intracellular content into the extracellular environment can trigger
inflammation by providing “danger” signals for the surrounding
cells and immune competent cells, such as dendritic cells, granu-
locytes, and monocytes (Sauter et al., 2000). However, at the same
time, viruses, which often use strategies to modulate the apoptotic
program, may profit from the available translation apparatus in the
necrotic cell to propagate until the cell eventually demises.
 
Materials and methods
 
Cell culture and induction of apoptosis or necrosis
 
Jurkat T cells were grown as described previously (Kalai et al., 2002). Pa-
rental E cells and JB6 cells were provided by S. Nagata (Osaka University
Medical School, Osaka, Japan). FADD-deficient cells were provided by J.
Blenis (Harvard Medical School, Boston, MA). 100 ng/ml CH-11 anti-Fas
antibody (BioCheck) was used to induce apoptosis in JE cells. 50 
 
 
 
g/ml
dsRNA (poly (I)-poly(C)) (Amersham Biosciences) and 5000 IU/ml of hu-
man TNF were used to induce necrosis in JB6 and FADD-deficient cells, re-
spectively. Caspases were blocked by incubating cells for 30 min with 25
 
 
 
M zVAD-fmk (Bachem) or quinoline-Val-Asp-O-phenoxy (MP Biomedi-
cals) before stimulation. Cell death was monitored by trypan blue exclu-
sion or by measuring PI (15 
 
 
 
M) uptake at 610 nm by FACS analysis us-
ing a FACScalibur flow cytometer (Becton Dickinson) equipped with a
488-nm Argon laser. ROS production was measured as the fluorescence
at 525 nm of rhodamine 123, resulting from oxidation of dihydro-
rhodamine 123 (Molecular Probes) in PI-negative cells. Dihydrorhodamine
123 was applied to the cells at 0.1 
 
 
 
M 30 min before analysis. Relative
fluorescence values are depicted as the ratio between the fluorescent sig-
nal at a given time point and the initial fluorescence for the same condi-
tion, using mean fluorescence values from a representative experiment
performed in triplicate. Caspase activity was determined as described us-
ing DEVD-amc as substrate (Saelens et al., 2001).
 
Microscopic analysis
 
Cells were seeded in normal growth medium in 8-chambered cover glass
(Nunc) and treated for the time indicated in the legends of Figs. 1 and 4.
Phase-contrast images and fluorescence images were photographed using
a microscope (model DM IRE2; Leica) equipped with a HCX PLAPO
63
 
 
 
/1.30 glycerine corrected 37
 
 
 
C lens and a coolsnap HQ camera.
Figure 4. Coxsackievirus induces necrosis-
like death. Cells were infected with CVB (multi-
plicity of infection of 20) for 1 h, washed, and
incubated for the time points indicated. (A)
CVB replicates in JE and JB6 cells. Y-axis
shows virus titer (in 50% tissue culture infective
dose/ml). (B) Microscopic analysis of JE (top)
and JB6 (bottom) cells infected with CVB for
16 h. Closed arrows indicate swollen cells;
open arrowheads indicate cells with nuclear
PI staining. (C) Jurkat cells do not display cas-
pase  activity following CVB infection. As a
control, a sample from anti-Fas–treated JE cells
was also analyzed (A-Fas). (D) Kinetics of cell
death following CVB infection of JE and JB6
cells, as measured by permeability to trypan
blue. (E) Translation rate of JE (left) and JB6
(right) cells infected in D. Coomassie and ra-
dioactivity signals from SDS-PAGE gels were
quantified by densitometry and phosphorim-
aging, respectively, and the ratio of 
35S-counts
over total protein in each lane were calculated.
Data in the graph are from one experiment
that was performed three times, giving similar
results. (F) Fate of eIF4G (top) and PARP (bottom)
in CVB-infected JE (left) and JB6 (right) cells.
Note that eIF4G is not cleaved into the apop-
totic 45-kD fragment, but, instead, into a 100-kD
fragment (eIF4GCVB). A-Fas, apoptotic lysates. 
JCB • VOLUME 168 • NUMBER 4 • 2005 550
 
The camera is controlled by the ASMDW acquisition software (Leica). PI
(1 
 
 
 
M) fluorescence was monitored at 540 nm using a 50-W Xe lamp for
excitation. Blind deconvolution of the fluorescence and overlay images
was performed using Metamorph 5.0 software.
 
Metabolic labeling of proteins
 
To avoid stress responses, metabolic labeling of the cells was performed in
normal growth medium. 16 h before labeling, cells were seeded at 10
 
6
 
cells/ml. At selected time points after stimulation, samples of 1.5 
 
 
 
 10
 
6
 
cells were transferred to a 6-well plate and labeled for 30 min with 10 
 
 
 
Ci
of Trans
 
35
 
S-label (MP Biomedicals). 10 
 
 
 
g/ml cycloheximide (CHX) was
added to cells 1 h before labeling. After pulse labeling, cells were washed
twice with ice-cold PBS and lysed on ice with caspase lysis buffer containing
10 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5 mM EDTA, 10% glycerol, 1%
NP-40, 1 mM aprotinin, 1 mM leupeptin, and 100 
 
 
 
M PMSF. From each
time point, 30 
 
 
 
g of protein from the 14,000 
 
g
 
 supernatant fraction was re-
solved by SDS-PAGE and visualized by Coomassie brilliant blue staining.
The intensity of the Coomassie-stained bands in each lane was quantified
by densitometry. After drying, 
 
35
 
S signals from the gels were captured and
quantified using a PhosphorImager (Bio-Rad Laboratories).
 
Immunoblot analysis
 
Protein extracts from cell lines were prepared by lysis with sample buffer,
separated in 12.5% SDS-PAGE gels, and transferred to nitrocellulose. An-
tibodies against the following antigens were used to probe the blots:
eIF4G and PKR (Transduction Laboratories), phosphorylated eIF2-
 
 
 
 (Re-
search Genetics), eIF2-
 
 
 
 (Santa Cruz Biotechnology, Inc.), PARP (BIOMOL
Research Laboratories, Inc.), phosphorylated-p38 MAPK (Biosource Inter-
national), and total p38 MAPK (Cell Signaling Technology). Immuno-reac-
tive proteins were visualized using chemiluminescence and signals were
captured by exposure to film (Amersham Biosciences). Bands on the lumi-
nographs were quantitated by densitometry using a Lumi-Imager worksta-
tion (Roche Molecular Biochemicals).
 
Analysis of rRNA
 
6 and 7 h after induction of apoptosis and necrosis, total RNA was pre-
pared using an RNeasy kit (QIAGEN). 10 
 
 
 
g of RNA was separated in
an agarose gel, using Tris-Borate-EDTA as running buffer, and stained
with ethidium bromide.
 
Viral infection
 
CVB used in this study was derived from plasmid pCB3/T7, containing a
cDNA of coxsackievirus type B3 (strain Nancy) behind a T7 RNA poly-
merase promoter. Viruses were grown and titrated on Buffalo green mon-
key kidney cells. Jurkat cells were infected for 1 h at 37
 
 
 
C at a multiplicity
of infection of 20 TCID50 (50% tissue culture infective dose) per cell.
Hereafter, cells were washed and incubated at 37
 
 
 
C for further analysis
at the indicated time periods. Viruses were extracted from the Jurkat cells
by three cycles of freeze thawing and titrated on Buffalo green monkey
kidney cells.
 
Online supplemental material
 
Fig. S1 shows that translation is rapidly shut down in apoptosis but not in
necrosis. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200407162/DC1.
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Figure 5. Induction of apoptosis in CVB-infected cells leads
to a drop in virus titer, whereas enhancing necrosis by
dsRNA-treatment of infected JB6 cells does not affect virus
propagation. CVB-infected JE (A and C) or JB6 (B and D)
cells were left untreated ( ) or stimulated with anti-Fas or
dsRNA, respectively, for 8 h, starting 2 h after infection.
(A and B) Cells were pulse-labeled with 
35S-methionine, and
the amount of incorporated 
35S in the protein fraction of cell
lysates and cell death was determined (top). Effects on
eIF4G and PARP were analyzed by immunoblotting (bottom).
(C and D) CVB titers from JE (C) and JB6 (D) infected cells
stimulated with anti-Fas or dsRNA or left untreated (ctr). Error
bars equal SD of the mean (n   3). 
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